SCHEMBL30484829

SCHEMBL30484829

CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 1/20 0.42
▸ NPY2R P49146 1/20 0.42
▸ NPY4R P50391 1/20 0.42
▸ NMT2 O60551 1/20 0.42
▸ NMT1 P30419 1/20 0.42
▸ MME P08473 3/20 0.41
▸ ERAP2 Q6P179 1/20 0.41
▸ ERAP1 Q9NZ08 1/20 0.41
▸ LNPEP Q9UIQ6 1/20 0.41
▸ UTS2R Q9UKP6 1/20 0.40
▸ GRIN2D O15399 1/20 0.40
▸ GRIN3B O60391 1/20 0.40
▸ GRIN1 Q05586 1/20 0.40
▸ GRIN2A Q12879 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40
▸ GRIN2C Q14957 1/20 0.40
▸ GRIN3A Q8TCU5 1/20 0.40
▸ KISS1R Q969F8 4/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ CPB2 Q96IY4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29473693 0.93 GRIN2D (0.44) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30484828 0.93 MME (0.47) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30484834 0.92 NPY4R (0.47) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL29473690 0.91 GRIN2D (0.47) NMT2NMT1MMEGRIN2DGRIN3B
SCHEMBL29886546 0.91 NMT1 (0.47) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30484831 0.91 NPY4R (0.46) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30484833 0.91 NPY4R (0.44) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL29473689 0.90 NPY4R (0.42) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL29473686 0.89 NMT2 (0.47) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30070295 0.89 FOLH1 (0.41) NMT2NMT1MMEUTS2RCPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552839-B2 Cyclic peptides for protection against respiratory syncytial virus VIROMETIX AG (CH) 2026-02-17 — — US disclosed
US-20240287143-A1 CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS Universität Zürich (CH) 2024-08-29 — — US disclosed
US-11680085-B2 Cyclic peptides for protection against respiratory syncytial virus VIROMETIX AG (CH) 2023-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11680085-B2 Cyclic peptides for protection against respiratory syncytial virus VIP, LNPEP, CSTB NPY1R 832/4885NPY2R 1244/4885NPY4R 862/4885
US-20240287143-A1 CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS VIP, QPCT, QPCTL NPY1R 246/4885NPY2R 654/4885NPY4R 171/4885
US-12552839-B2 Cyclic peptides for protection against respiratory syncytial virus CTH, VIP, CXCL10 NPY1R 678/4885NPY2R 1122/4885NPY4R 742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback